Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Parasite Immunol ; 45(10): e13005, 2023 10.
Article in English | MEDLINE | ID: mdl-37467029

ABSTRACT

Chagas disease is a neglected tropical disease with only two drugs available for treatment and the plant Cecropia pachystachya has several compounds with antimicrobial and anti-inflammatory activities. This study aimed to evaluate a supercritical extract from C. pachystachya leaves in vitro and in vivo against Trypanosoma cruzi. A supercritical CO2 extraction was used to obtain the extract (CPE). Cytotoxicity and immunostimulation ability were evaluated in macrophages, and the in vitro trypanocidal activity was evaluated against epimastigotes and trypomastigotes forms. In vivo tests were done by infecting BALB/c mice with blood trypomastigotes forms and treating animals orally with CPE for 10 days. The parasitemia, survival rate, weight, cytokines and nitric oxide dosage were evaluated. CPE demonstrated an effect on the epi and trypomastigotes forms of the parasite (IC50 17.90 ± 1.2 µg/mL; LC50 26.73 ± 1.2 µg/mL) and no changes in macrophages viability, resulting in a selectivity index similar to the reference drug. CPE-treated animals had a worsening compared to non-treated, demonstrated by higher parasitemia and lower survival rate. This result was attributed to the anti-inflammatory effect of CPE, demonstrated by the higher IL-10 and IL-4 values observed in the treated mice compared to the control ones. CPE demonstrated a trypanocidal effect in vitro and a worsening in the in vivo infection due to its anti-inflammatory activity.


Subject(s)
Chagas Disease , Triterpenes , Trypanocidal Agents , Trypanosoma cruzi , Mice , Animals , Parasitemia/drug therapy , Trypanocidal Agents/pharmacology , Trypanocidal Agents/therapeutic use , Chagas Disease/drug therapy , Trypanosoma cruzi/physiology , Mice, Inbred BALB C , Triterpenes/pharmacology , Triterpenes/therapeutic use , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Ursolic Acid
2.
Eur J Dent ; 15(1): 101-108, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32898869

ABSTRACT

OBJECTIVES: Conduct a histological comparison of the pulp response to different materials, with a focus on the continuity and morphology of the mineralized barrier after direct pulp capping. MATERIALS AND METHODS: One hundred and eight maxillary first molars of 54 Wistar rats were subject to direct pulp capping and divided into three groups according to the materials used: calcium hydroxide (CH), mineral trioxide aggregate (MTA), and Biodentine. All cavities were sealed, and the animals were euthanized at 7, 14, and 21 days. Descriptive histological evaluation of the inflammation and formation of the mineralized barrier was performed. STATISTICAL ANALYSIS: Statistical analyses were performed using the Kruskal-Wallis test, which was complemented by the Dunn test; differences with p < 0.05 were considered statistically significant. RESULTS: The results showed that MTA and Biodentine elicited less intense inflammatory reactions than CH. With respect to the formation and quality of the dentin barrier formed, differences were observed at 21 days between the analyzed groups; the best results being obtained following treatment with MTA and Biodentine. CONCLUSION: MTA and Biodentine induced formation of a more continuous and uniform mineralized barrier with less intense pulp response than CH.

3.
Alcohol Clin Exp Res ; 37(1): 49-56, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22725841

ABSTRACT

BACKGROUND: Ethanol (EtOH) alters the all-trans-retinoic acid (ATRA) levels in some tissues. Retinol and ATRA are essential for cell proliferation, differentiation, and maintenance of prostate homeostasis. It has been suggested that disturbances in retinol/ATRA concentration as well as in the expression of retinoic acid receptors (RARs) contribute to benign prostate hyperplasia and prostate cancer. This study aimed to evaluate whether EtOH consumption is able to alter retinol and ATRA levels in the plasma and prostate tissue as well as the expression of RARs, cell proliferation, and apoptosis index. METHODS: All animals were divided into 4 groups (n = 10/group). UChA: rats fed 10% (v/v) EtOH ad libitum; UChACo: EtOH-naïve rats without access to EtOH; UChB: rats fed 10% (v/v) EtOH ad libitum; UChBCo: EtOH-naïve rats without access to EtOH. Animals were euthanized by decapitation after 60 days of EtOH consumption for high-performance liquid chromatography and light microscopy analysis. RESULTS: EtOH reduced plasma retinol concentration in both UChA and UChB groups, while the retinol concentration was not significantly different in prostate tissue. Conversely, plasma and prostate ATRA levels increased in UChB group compared with controls, beyond the up-regulation of RARß and -γ in dorsal prostate lobe. Additionally, no alteration was found in cell proliferation and apoptosis index involving dorsal and lateral prostate lobe. CONCLUSIONS: We conclude that EtOH alters the plasma retinol concentrations proportionally to the amount of EtOH consumed. Moreover, high EtOH consumption increases the concentration of ATRA in plasma/prostate tissue and especially induces the RARß and RARγ in the dorsal prostate lobe. EtOH consumption and increased ATRA levels were not associated with cell proliferation and apoptosis in the prostate.


Subject(s)
Alcohol Drinking/blood , Ethanol/pharmacology , Prostate/drug effects , Prostate/pathology , Receptors, Retinoic Acid/metabolism , Tretinoin/blood , Animals , Apoptosis/drug effects , Cell Proliferation/drug effects , Central Nervous System Depressants/pharmacology , Male , Prostate/metabolism , Rats , Rats, Wistar
4.
Reprod Biol Endocrinol ; 9: 160, 2011 Dec 22.
Article in English | MEDLINE | ID: mdl-22192617

ABSTRACT

BACKGROUND: Variations in maternal care are associated with neonatal stress, hormonal disturbances and reproductive injuries during adulthood. However, the effects of these variations on sex hormones and steroid receptors during ovary development remain undetermined. This study aimed to investigate whether variations in maternal care are able to influence the hormonal profile, follicular dynamics and expression of AR, ER-alpha and ER-beta in the ovaries of UCh rat offspring. METHODS: Twenty-four adult UCh rats, aged 120 days, were randomly divided into two groups (UChA and UChB) and mated. Maternal care was assessed from birth (day 0) to the 10th postnatal day (PND). In adulthood, twenty adult female rats (UChA and UChB offspring; n = 10/group), aged 120 days, were euthanized by decapitation during the morning estrus. RESULTS: UChA females (providing high maternal care) more frequently displayed the behaviors of carrying pups, as well as licking/grooming and arched back nursing cares. Also, mothers providing high care had elevated corticosterone levels. Additionally, offspring receiving low maternal care showed the highest estrous cycle duration, increased corticosterone and 17beta-estradiol levels, overexpression of receptors ER-alpha and ER-beta, increased numbers of primordial, antral and mature follicles and accentuated granulosa cell proliferation. CONCLUSIONS: Our study suggests that low maternal care alters corticosterone and 17beta-estradiol levels, disrupting the estrous cycle and folliculogenesis and differentially regulating the expression of ER-alpha and ER-beta in the ovaries of adult rats.


Subject(s)
Estrous Cycle/physiology , Hormones/blood , Maternal Behavior/physiology , Ovarian Follicle/growth & development , Ovary/metabolism , Receptors, Estrogen/metabolism , Animals , Animals, Newborn , Blotting, Western , Corticosterone/blood , Estradiol/blood , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Female , Immunohistochemistry , Ki-67 Antigen/metabolism , Male , Ovarian Follicle/cytology , Rats , Rats, Inbred Strains , Time Factors
5.
Reprod Biol Endocrinol ; 9: 108, 2011 Aug 02.
Article in English | MEDLINE | ID: mdl-21810236

ABSTRACT

BACKGROUND: Melatonin is associated with direct or indirect actions upon female reproductive function. However, its effects on sex hormones and steroid receptors during ovulation are not clearly defined. This study aimed to verify whether exposure to long-term melatonin is able to cause reproductive hormonal disturbances as well as their role on sex steroid receptors in the rat ovary, oviduct and uterus during ovulation. METHODS: Twenty-four adult Wistar rats, 60 days old (+/-250 g) were randomly divided into two groups. Control group (Co): received 0.9% NaCl 0.3 mL+95% ethanol 0.04 mL as vehicle; Melatonin-treated group (MEL): received vehicle+melatonin [100 µg/100 g BW/day] both intraperitoneally during 60 days. All animals were euthanized by decapitation during the morning estrus at 4 a.m. RESULTS: Melatonin significantly reduced the plasma levels of LH and 17 beta-estradiol, while urinary 6-sulfatoximelatonin (STM) was increased at the morning estrus. In addition, melatonin promoted differential regulation of the estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR) and melatonin receptor (MTR) along the reproductive tissues. In ovary, melatonin induced a down-regulation of ER-alpha and PRB levels. Conversely, it was observed that PRA and MT1R were up-regulated. In oviduct, AR and ER-alpha levels were down-regulated, in contrast to high expression of both PRA and PRB. Finally, the ER-beta and PRB levels were down-regulated in uterus tissue and only MT1R was up-regulated. CONCLUSIONS: We suggest that melatonin partially suppress the hypothalamus-pituitary-ovarian axis, in addition, it induces differential regulation of sex steroid receptors in the ovary, oviduct and uterus during ovulation.


Subject(s)
Estradiol/blood , Fallopian Tubes/metabolism , Luteinizing Hormone/blood , Melatonin/pharmacology , Ovary/metabolism , Receptors, Steroid/metabolism , Uterus/metabolism , Animals , Fallopian Tubes/drug effects , Female , Ovary/drug effects , Ovulation , Rats , Rats, Wistar , Receptor, Melatonin, MT1/drug effects , Reproduction/drug effects , Uterus/drug effects
6.
Alcohol Clin Exp Res ; 35(8): 1498-508, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21438888

ABSTRACT

BACKGROUND: Chronic ethanol intake leads to reproductive damage including reactive oxygen species formation, which accelerates the oxidative process. Melatonin is known to regulate the reproductive cycle, food/liquid intake, and it may also act as a potent antioxidant indoleamine. The aim of this study was to verify the effects of alcoholism and melatonin treatment on overall feed efficiency and to analyze its protective role against the oxidative stress in the ovarian tissue of UChB rats (submitted to 10% [v/v] voluntary ethanol consumption). METHODS: Forty adult female rats (n = 10/group) were finally selected for this study: UChB Co: drinking water only; and UChB EtOH: drinking ethanol at 2 to 6 ml/100 g/d + water, both receiving 0.9% NaCl + 95% ethanol 0.04 ml as vehicle. Concomitantly, UChB Co + M and UChB EtOH + M groups were infused with vehicle + melatonin (100 µg/100 g body weight/d) intraperitoneally over 60 days. All animals were euthanized by decapitation during the morning estrus (4 am). RESULTS: Body weight gain was reduced with ethanol plus melatonin after 40 days of treatment. In both melatonin-treated groups, it was observed a reduction in food-derived calories and liquid intake toward the end of treatment. The amount of consumed ethanol dropped during the treatment. Estrous cycle was longer in rats that received both ethanol and melatonin, with prolonged diestrus. Following to oxidative status, lipid hydroperoxide levels were higher in the ovaries of ethanol-preferring rats and decreased after melatonin treatment. Additionally, antioxidant activities of superoxide dismutase, glutathione peroxidase activity, and glutathione reductase activity were increased in melatonin-treated groups. CONCLUSIONS: We suggest that melatonin is able to affect feed efficiency and, conversely, it protects the ovaries against the oxidative stress arising from ethanol consumption.


Subject(s)
Antioxidants/pharmacology , Melatonin/pharmacology , Ovary/drug effects , Oxidative Stress/drug effects , Alcohol Drinking/pathology , Animals , Antioxidants/administration & dosage , Body Weight/drug effects , Central Nervous System Depressants/pharmacology , Central Nervous System Depressants/toxicity , Estrous Cycle/drug effects , Ethanol/pharmacology , Ethanol/toxicity , Feeding Behavior/drug effects , Female , Glycemic Index/drug effects , Injections, Intraperitoneal , Melatonin/administration & dosage , Ovary/injuries , Protective Agents/pharmacology , Rats , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...